Related by context. All words. (Click for frequent words.) 87 HES CEL 82 myelodysplastic myeloproliferative diseases 79 chronic eosinophilic leukemia 74 hypereosinophilic syndrome 74 R Saizen R 73 aggressive systemic mastocytosis 73 hyperphenylalaninemia HPA due 71 headache abdominal pain 70 R lenalidomide 70 included exfoliative dermatitis 70 TNF Tumor Necrosis Factor 70 Known hypersensitivity 69 induce orthostatic hypotension 69 hematological parameters 69 tumor lysis syndrome 69 Pegloticase 69 receiving XGEVA 68 neutropenia dehydration dyspnea 68 aspartate aminotransferase AST 68 deep venous thromboses 68 nicardipine 68 Patients Treated With 68 interferon beta 1a infertility 68 refractory chronic lymphocytic 68 dasatinib Sprycel ® 68 Investigational Treatment 68 ® lenalidomide 68 receiving VELCADE 68 AST ALT 68 Zorbtive TM 68 metastatic malignant 68 Demonstrates Positive 68 R metformin Concor 67 SGPT 67 bone marrow reticulin deposition 67 CYT# potent vascular disrupting 67 Coadministration 67 erlotinib Tarceva ® 67 PEGylated anti 67 Nebulized 67 aspartate aminotransferase 67 neutropenia thrombocytopenia 67 grade cervical intraepithelial 67 Pharmacokinetics PK 67 subependymal giant cell 67 hypertrichosis occurred 67 serum phosphorous 67 purpura ITP 67 BCG refractory carcinoma 67 unresectable recurrent 67 vapreotide acetate 67 rheumatoid arthritis osteoarthritis ankylosing 67 Patients Receiving 67 endothelin receptor antagonists 67 Dementia Related Psychosis 67 anemia thrombocytopenia 67 intravesical therapy 67 Relapsed Refractory 67 vinca alkaloid 67 Long Term Efficacy 66 headache nasopharyngitis 66 Heterozygous Familial Hypercholesterolemia 66 PEGylated interferon beta 1a 66 Phase 2b Clinical Trial 66 valsartan amlodipine 66 severe hypersensitivity reactions 66 Mg Uk 66 non splenectomized 66 recurrent glioblastoma multiforme 66 hypercalcemia 66 Refractory Hodgkin Lymphoma 66 alpha interferons 66 SPRYCEL ® 66 Complicated Skin 66 Cutaneous T 66 ß blockers 66 essential thrombocythemia ET 66 TO AVOID PREGNANCY WHILE 66 Meets Primary Endpoint 66 urinary N telopeptide 66 severe renal impairment 66 Adjuvant Treatment 66 Danazol 66 ritonavir boosted 66 tryptase 66 DOXIL 66 dual endothelin receptor antagonist 66 substantially excreted 66 hyperplasia BPH 66 CTAP# 66 Initiates Clinical Trial 66 methylnaltrexone bromide 66 Hematologic 66 leukopenia pancytopenia thrombocytopenia 66 nephrotoxicity 66 haematologic 66 pyrexia mucositis sepsis febrile 66 Newly Diagnosed Multiple Myeloma 66 polycythemia vera essential thrombocythemia 66 PEGylated Fab fragment 66 R bisoprolol Euthyrox 66 peripherally acting 65 patients coinfected 65 five MDS subtypes 65 Antitumor Activity 65 myopathy rhabdomyolysis 65 Toxicities 65 administered concomitantly 65 sorafenib tablets 65 ergot derivatives 65 deletion 5q 65 Fludara ® 65 CIMZIA TM certolizumab pegol 65 PEGINTRON TM 65 MAGE A3 ASCI 65 venlafaxine Effexor 65 elevated ALT 65 serologically active systemic lupus 65 imatinib Gleevec ® 65 metastatic colorectal carcinoma 65 Hypokalemia 65 ACTEMRA TM 65 Vidaza ® 65 5 FU leucovorin 65 non metastatic osteosarcoma 65 FUSILEV enhances 65 J Am Coll 65 Warfarin Coumadin 65 Orally Active 65 humanised monoclonal antibody 65 limiting toxicity DLT 65 acute humoral rejection 65 MEK Inhibitor 65 docetaxel Taxotere ® 65 CYP#A# CYP#D# 65 melphalan prednisone 65 Ribavirin causes 65 Adjunctive 65 thalidomide Thalomid 65 cough dyspnea 65 alfuzosin 65 TRAIL R1 65 unfavorable cytogenetics 65 Gel repository corticotropin injection 65 Navelbine ® 65 Naive Patients 65 pseudobulbar affect PBA 65 decompensated liver disease 65 Peginterferon alfa 2b 65 heparin induced thrombocytopenia 65 INVANZ 65 Philadelphia Chromosome Positive 65 interleukin IL -# 65 HMG CoA reductase inhibitors 65 nasopharyngitis headache 65 mild renal insufficiency 65 coadministration 65 FluCAM arm 65 nonhematologic adverse reactions 65 INSPIRE Trial Phase III 65 elevated serum creatinine 65 Atypical Hemolytic Uremic Syndrome 65 danazol 64 hypokalemia hypomagnesemia 64 Teriflunomide 64 Myelodysplastic Syndrome MDS 64 ARCALYST ® 64 brand ciclesonide HFA 64 Secondary Hyperparathyroidism 64 Hsp# Inhibitor 64 See CLINICAL PHARMACOLOGY 64 demonstrated antitumor activity 64 smoldering multiple myeloma 64 nausea vomiting headache 64 Progressive Multifocal Leukoencephalopathy 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 Mg Usa 64 post herpetic 64 erythropoietic 64 induced mucositis 64 Azacitidine 64 Fidaxomicin 64 Fondaparinux 64 alfa 2a 64 ribavirin USP 64 Cardiotoxicity 64 BEXXAR Therapeutic Regimen 64 lipid elevations 64 novel VDA molecule 64 antidepressants fluoxetine 64 Receives Orphan Drug Designation 64 K ras mutations 64 primidone 64 alanine aminotransferase 64 Carbamazepine 64 hypophosphatemia 64 IMiDs ® compound 64 INCB# [003] 64 elevated transaminases 64 risperidone Risperdal 64 Thiazolidinediones 64 invasive candidiasis 64 monoclonal antibody IgG1 Mab 64 aplastic anemia AA 64 Intravitreal injections 64 cisplatin gemcitabine 64 symptomatic hyponatremia 64 Renal Impairment 64 denileukin diftitox 64 sapropterin dihydrochloride Tablets 64 receiving INTRON 64 adalimumab Humira 64 oral antidiabetic medication 64 xanthine oxidase inhibitor 64 Tyrosine Kinase Inhibitor 64 thrombocytopenia neutropenia 64 TMP SMX 64 BENICAR HCT 64 papillary renal cell carcinoma 64 myocardial infarction ventricular fibrillation 64 oxycodone CR 64 macrolide antibiotic 64 plasma pharmacokinetics 64 candidates Azedra TM 64 orally inhaled migraine 64 Aflibercept 64 COPEGUS therapy 64 diabetic gastroparesis 64 Novel Oral 64 Tolvaptan 64 aripiprazole Abilify 64 IIIa inhibitor 64 mGluR5 NAM 64 lipid lowering agents 64 elevated creatinine 64 Kit CD# positive 64 grade squamous intraepithelial 64 erythematosus 64 esophageal candidiasis 64 hepatic insufficiency 64 FDA APPROVES 64 chronic immune thrombocytopenic 64 Letairis ambrisentan 64 Drug Candidate 64 bevacizumab Avastin ® 64 Hypersensitivity reactions 64 sorafenib Nexavar 64 TELINTRA 64 receiving prophylactic anticoagulation 64 mcg kg REBETOL 64 evaluating tivozanib 64 intravascular hemolysis 64 Myelosuppression 64 diarrhea dyspepsia 64 lamotrigine Lamictal 64 Abrupt discontinuation 64 Eculizumab 64 myeloproliferative diseases 64 PREZISTA r 64 acute GvHD 64 palifermin 64 gastrointestinal stromal tumors GISTs 64 VP# [004] 64 Methylnaltrexone 64 Erythropoietic therapies may 64 systemic hypotension 64 Achieves Primary Endpoint 64 constipation OIC 64 liposomal amphotericin B 64 Orthostatic Hypotension 64 Intra arterial 64 Serostim ® 64 hyaluronidase enzyme 64 CTAP# Capsules 64 catheter occlusion 64 Tumor Response 64 inhalation powder 64 pheochromocytoma 64 gastrointestinal mucositis 64 Adenomas 64 potent CYP#A# inhibitors 64 topical gel formulation 64 idarubicin 63 metastatic pancreatic 63 dopamine D2 63 Estrogen Receptor 63 nucleoside analog 63 ADP receptor antagonist 63 Mycophenolate Mofetil 63 Leukemias 63 bronchial hyperresponsiveness 63 BARACLUDE ® 63 Metastatic Prostate Cancer 63 Mitoxantrone 63 Initiate Clinical Trial 63 nilotinib Tasigna ® 63 Vidaza azacitidine 63 advanced metastatic renal 63 anaphylactic reactions bronchospasm 63 TNF blocker therapy 63 Pafuramidine 63 leukemia AML 63 unresectable tumors 63 tumors GIST 63 candesartan cilexetil 63 chronic thromboembolic pulmonary 63 CIMZIA R 63 dermatologic reactions 63 Chronic Renal Failure 63 myelofibrosis polycythemia vera 63 invasive aspergillosis 63 extrapyramidal symptoms EPS 63 IMiDs ® 63 acid phosphatase PAP 63 fluvastatin 63 Acute Bacterial Sinusitis ABS 63 Prostatic 63 pralatrexate injection folate analogue 63 Intravitreal 63 receptor tyrosine kinase inhibitor 63 hydroxymethyl coenzyme 63 dihydrochloride 63 leukemia CLL 63 HER2 overexpression 63 Prolongs Survival 63 Improves Outcomes 63 recurrent DVT 63 VAPRISOL 63 relapsed MM 63 signal transduction inhibitors 63 thromboembolic complications 63 NAVISTAR R 63 torsade de pointes 63 Soft Tissue Sarcoma 63 reactogenicity 63 Bosutinib 63 Sodium oxybate 63 fosbretabulin 63 SGOT 63 BUPHENYL R sodium phenylbutyrate 63 Anthracycline 63 4mg/kg 63 Sudhir Agrawal D.Phil 63 dexamethasone Decadron 63 Malignant Glioma 63 Relapsed Refractory Multiple Myeloma 63 MULTAQ 63 pulmonary hypertension PH 63 neovascular diseases 63 Demonstrate Significant 63 ipratropium bromide 63 Selective Inhibitor 63 developing Bicifadine serotonin 63 stage IIIb IV 63 VELCADE melphalan 63 Peginterferon 63 malignancy HCM 63 Lubiprostone 63 p# inhibitor 63 Dasatinib 63 ACTOplus met XR 63 bendamustine ifosfamide 63 Platinol ® 63 Initiates Enrollment 63 XL# anticancer compounds 63 cTnI 63 Chronic Heart Failure 63 paroxetine Paxil 63 biologic DMARD 63 corticotropin injection 63 prokinetic agent 63 splenectomized 63 Paxil paroxetine 63 Epidermal Growth Factor Receptor 63 colorectal adenoma 63 selective modulator 63 octreotide implant 63 JAK2 Inhibitor 63 trastuzumab Herceptin R 63 serum phosphate 63 abacavir lamivudine 63 hemorrhagic cystitis 63 #q# deletion syndrome 63 Lactic acidosis 63 hepatic metastases 63 cytopenias 63 metastatic GIST 63 interferon alfa 2b 63 posterior uveitis 63 Shows Statistically Significant 63 Non inferiority 63 metformin accumulation 63 Plaque Psoriasis 63 dasatinib Sprycel 63 paroxetine sertraline 63 INVEGA ® 63 acute peptic ulcer 63 Tolerability 63 micafungin 63 relapsed Acute Myeloid 63 paclitaxel cisplatin 63 immunomodulatory therapy 63 AVASTIN 63 β blockers 63 metastatic colorectal 63 prolonged QT interval 63 kidney urologic 63 Aliskiren 63 Asymptomatic 63 TNF Blockers 63 Monotherapy 63 G CSFs 63 asthma rhinitis 63 relapsing multiple sclerosis 62 either acutely decompensated 62 Basal Cell 62 Patients Undergoing 62 Gamunex C 62 tigecycline 62 anticholinergic agents 62 Castration Resistant Prostate Cancer 62 oral prodrug 62 metformin sulfonylurea 62 NATRECOR ® 62 bevacizumab Avastin R 62 chronic idiopathic thrombocytopenic purpura 62 5 fluorouracil leucovorin 62 Selective Serotonin Reuptake Inhibitor 62 undergoing elective percutaneous 62 moderate renal impairment 62 Primary Hypercholesterolemia 62 APTIVUS r 62 TNF antagonist 62 BPH benign prostatic 62 OMNARIS HFA 62 Romiplostim 62 Navelbine 62 anthracycline containing 62 EGFR HER2 62 Cytarabine 62 intranasal formulation 62 weekly subcutaneous injections 62 sunitinib Sutent ® 62 Interferon beta 1a 62 anthracycline taxane 62 systemic corticosteroid 62 Intrathecal 62 R Bortezomib 62 investigational monoclonal antibody 62 tiagabine 62 infectious diseases autoimmune diseases 62 MGd 62 direct thrombin inhibitors 62 PSA nadir 62 ara C 62 thromboembolic events 62 acetonide FA 62 rabeprazole 62 lichen planus 62 NOLVADEX 62 chronic myeloid 62 idiopathic thrombocytopenic purpura ITP 62 unfractionated heparin UFH 62 methicillin susceptible Staphylococcus aureus 62 R sorafenib tablets 62 metabolic alkalosis 62 aspirin clopidogrel 62 hepatorenal syndrome 62 adriamycin 62 novel emulsion formulation 62 C Reactive Protein 62 posaconazole 62 dopamine partial agonist 62 Natalizumab 62 HERCEPTIN 62 Renal Artery 62 Doxil ® 62 vitreous floaters 62 mecamylamine 62 morphometric vertebral fractures 62 oral levofloxacin 62 renal toxicity 62 plus prednisone prednisolone 62 IONSYS TM 62 somatostatin analog 62 superficial bladder cancer 62 #.#mg/dL 62 LHRH receptor positive 62 beclomethasone dipropionate 62 Presents Positive 62 benazepril 62 hypercalciuria 62 Demonstrates Efficacy 62 aldosterone antagonist 62 GOUT 62 AAG geldanamycin analog 62 serotonin norepinephrine reuptake inhibitors 62 reduce serum phosphate 62 leukotriene receptor antagonists 62 hypocalcemia 62 phenytoin Dilantin 62 receiving highly emetogenic 62 NMDA antagonists 62 pruritus rash 62 atypical hemolytic uremic syndrome 62 basiliximab 62 HBeAg positive patients 62 sertraline Zoloft 62 QVAR ® 62 injectable bulking agent 62 ALT normalization 62 dextromethorphan quinidine 62 antiplatelet medications 62 receiving immunosuppressive therapy 62 Panzem R 62 Tasigna prolongs 62 Thrombotic thromboembolic complications 62 bladder ovarian 62 Immunotherapeutic 62 ovarian carcinoma 62 cell carcinoma RCC 62 2 methoxyestradiol 62 Shows Efficacy 62 GERD migraine headaches 62 proprietary intravenous formulation 62 NAGS deficiency 62 antimetabolite 62 erythema nodosum 62 complement inhibitor eculizumab 62 Belimumab 62 Hemodialysis Patients 62 5 Fluorouracil 62 Atripla combines 62 HBeAg negative patients 62 ACE Inhibitors 62 VEGFR2 inhibitor 62 hypercholesterolaemia 62 Reduces Mortality 62 metastatic castration resistant 62 Lenalidomide 62 psoriatic arthritis PsA 62 pathophysiological effects 62 Prognostic significance 62 Combination REOLYSIN R 62 Tumor Necrosis Factor 62 Simulect 62 Ecallantide 62 Testosterone deficiency 62 Entereg R 62 exocrine pancreatic insufficiency EPI 62 angiotensin II receptor blockers 62 dermatologic toxicities 62 cetuximab Erbitux ® 62 discontinued Viread 62 stage IIIB 62 RoACTEMRA 62 Ph + acute lymphoblastic 62 ZOLINZA 62 AGHD 62 Orally administered 62 haematologic malignancies 62 Paraplatin ® 62 mild hepatic impairment 62 Factor Receptor 62 abnormal p# 62 mcg BID 62 pioglitazone HCl 62 metastatic gastric 62 secondary hyperparathyroidism 62 primary hyperparathyroidism 62 humanized therapeutic 62 agent VDA 62 Tigecycline 62 Aggrastat ® tirofiban hydrochloride 62 citalopram Celexa 62 overactive bladder syndrome 62 trastuzumab Herceptin ® 62 metastatic neuroendocrine tumors 62 polyneuropathy HIV DSP 62 pretransplant 62 severe hepatic insufficiency 62 EpCAM expression 62 riociguat 62 Pegylated Liposomal Doxorubicin 62 Annamycin 61 PROCRIT ® 61 elevated LDL cholesterol 61 ULTRAM ER 61 esophagogastric 61 interferon gamma 1b 61 tumor histology 61 Cyclooxygenase 2 61 HCl PEPCID ® famotidine 61 alanine aminotransferase ALT 61 refractory NSCLC 61 pancreatic prostate 61 diabetic peripheral neuropathic DPN 61 Captopril 61 myeloperoxidase 61 generation purine nucleoside 61 Eltrombopag 61 vWD 61 oxymorphone ER 61 mitoxantrone plus 61 oral picoplatin 61 lymphomas leukemias 61 serum calcium levels 61 epithelial tumors 61 Adalimumab 61 cromolyn sodium 61 blood phenylalanine Phe 61 IOP lowering 61 pretest probability 61 gastrointestinal stromal tumors GIST 61 Hyperuricemia 61 Nesiritide 61 BZA CE 61 Fibrates 61 postoperative AF 61 BENICAR 61 diabetic neuropathic pain 61 heparanase 61 pelvic malignancies 61 ritonavir boosted protease inhibitor 61 lupus erythematosus 61 Nucleoside 61 Zometa hazard 61 CYP#A# substrate 61 8mg/kg 61 Levels Linked 61 Secondary endpoints included 61 antibody MAb 61 leiomyomas 61 FOLFOX6 61 aminotransferases 61 #mg BID [001] 61 gadobutrol 61 Pegasys ® 61 Glucocorticoid 61 allogeneic HSCT 61 Sebivo 61 dihydroergotamine 61 EGFR TKI 61 relapsed ALL 61 visilizumab 61 antiarrhythmic drug 61 alkylating agents 61 Endometrial 61 Mitomycin C 61 LHRH antagonists 61 humanized interleukin 6 61 containing abacavir 61 ulcerative colitis Crohn disease 61 febrile neutropenia 61 Microalbuminuria 61 Multidrug 61 bullous 61 metastatic renal 61 alpha 2a 61 tirofiban 61 CCyR 61 infarction NSTEMI 61 azilsartan medoxomil 61 Aztreonam lysine 61 C1 INH deficiency 61 atypical Hemolytic Uremic Syndrome 61 convulsive disorders 61 Fluticasone 61 Nilotinib 61 Shows Promise Against 61 Multiple Myeloma MM 61 postmenopausal osteoporotic women 61 endothelin antagonists 61 BUPHENYL R 61 Melphalan 61 certolizumab 61 lenalidomide dexamethasone 61 prostanoid 61 hepatic enzyme 61 endometrial hyperplasia 61 alpha1 antitrypsin deficiency 61 antiemetics 61 anemia leukopenia 61 irinotecan containing 61 clinicopathological features 61 Demonstrates Significant 61 mycophenolate mofetil MMF 61 abacavir Ziagen 61 bronchoalveolar lavage 61 Prilosec omeprazole 61 TRANSDUR ® 61 vWF 61 homozygous familial hypercholesterolemia 61 apolipoprotein B 61 alefacept 61 thetreatment 61 Pemetrexed 61 Posaconazole 61 Chemophase 61 T1c 61 Chronic Myelogenous Leukemia 61 TRIOLEX HE# APOPTONE HE# 61 ribavirin RBV 61 antiangiogenic agent 61 Glucocorticoids 61 hormone refractory metastatic prostate 61 Femara letrozole 61 Score TOS 61 urothelial carcinoma 61 Bronchiectasis 61 infusional 61 Elitek 61 thiazolidinedione TZD 61 Hypertriglyceridemia 61 porcine derived 61 Lymphocytic 61 galiximab 61 fluvoxamine Luvox 61 ATACAND 61 DMARDS 61 LymphoStat B belimumab 61 therapeutically inactive prodrug 61 triggers apoptosis programmed 61 comparator arm 61 tranylcypromine 61 potassium binder 61 carmustine 61 Fludarabine 61 hemodynamically significant 61 systemic immunosuppressive drugs 61 Services #:#-#,# Abstract 61 stable angina pectoris 61 TYGACIL 61 pharmacologically active isomer 61 vinorelbine tartrate 61 diclofenac Voltaren 61 Xeloda ® 61 pharmacokinetic interactions 61 serum prostate 61 aromatase inhibitors AIs 61 EFFEXOR XR 61 Vaprisol 61 leukemia multiple myeloma 61 Certolizumab pegol 61 bronchodilator therapy 61 Blinatumomab 61 D aspartate NMDA receptor 61 antiepileptics 61 Phase IIa Trial 61 Voreloxin 61 cardiovascular calcification 61 NMIBC 61 cause cardiac channelopathies 61 hepatocellular 61 prostate TURP 61 HIV HCV coinfected 61 renal scarring 61 locoregional recurrence 61 Daclizumab 61 VEGF inhibitors 61 HER2 expression 61 angiotensin converting enzyme inhibitor 61 opioid induced constipation OIC 61 Noxafil 61 opioid naive 61 Decitabine 61 clomipramine 61 nevirapine Viramune 61 plus prednisone 61 Hypotension 61 infliximab monotherapy 61 Deforolimus 61 Oral corticosteroids 61 haematological malignancies 61 Folfox 61 CINQUIL 61 Keppra R 61 VIIBRYD 61 lipid parameters 61 Esophageal 61 IAP inhibitor 61 Submits NDA 61 systemic juvenile idiopathic 61 esophageal carcinoma 61 Riluzole 61 EDEMA3 trial 61 histone deacetylase inhibitor 61 Lupus Nephritis 61 Lymphoid 61 dose melphalan 61 panitumumab Vectibix 61 lansoprazole Prevacid 61 Sapacitabine 61 Chronic HCV 61 thromboembolism 61 aplindore 61 Generalized Anxiety Disorder 61 Diovan HCT 61 known sulfonamide allergy 61 CIMZIA TM 61 colorectal carcinoma 61 LEP ETU 61 MKC# MT 61 Endometrial Cancer 61 transaminase elevations 61 thienopyridines 61 proguanil 61 investigational oral inhibitor 61 Lopressor 61 dalteparin 61 INTEGRILIN R 61 constipation nausea 61 prochlorperazine 61 pancreatic enzyme replacement 61 relapsed leukemia 61 Hypertrophy 61 Severe cutaneous 61 Prostacyclin 61 Hydralazine 61 OADs 61 conventional DMARDs 61 estrogen receptor beta agonist 61 Hyperkalemia 61 tolterodine ER 60 peptide BNP 60 efaproxiral 60 Inhalation Solution 60 occlusive disease 60 aminotransferase levels 60 alvespimycin 60 Aviptadil 60 lenalidomide Revlimid R 60 Cleviprex TM clevidipine 60 RAPAMUNE 60 extrapyramidal symptoms 60 Apolipoprotein B 60 Irinotecan 60 glutamic acid decarboxylase 60 Zoraxel 60 herpetic keratitis 60 Hurthle cell 60 calcineurin inhibitor 60 d l leucovorin 60 Thrombotic 60 tuberous sclerosis TS 60 unstable angina UA 60 salmeterol fluticasone 60 dose cytarabine 60 systemically administered 60 FOR FURTHER INFORMATION ABOUT 60 Malignancies 60 NSAID associated 60 platelet inhibitor 60 grade prostatic intraepithelial 60 variceal hemorrhage 60 acadesine 60 relapsed SCLC 60 hypogonadotropic hypogonadism 60 MTP inhibitor 60 injectable investigational 60 basal cell carcinoma BCC 60 liver histology 60 AMMONUL R sodium phenylacetate 60 Novel Compound 60 hepatotoxicity 60 calcium antagonists 60 histological subtype 60 histologic subtype 60 BELIEFS AS TO 60 metaglidasen 60 Zevalin R Ibritumomab 60 torsemide ER 60 Upregulation 60 coagulation abnormalities 60 omeprazole Prilosec 60 propranolol Inderal 60 adefovir dipivoxil 60 hematologic adverse 60 Clinical Trial Evaluating 60 Cimzia TM 60 clevidipine 60 serum ALT 60 Cariprazine 60 recurrent glioma 60 QTc prolongation 60 Paroxysmal Nocturnal Hemoglobinuria PNH 60 Myelodysplastic Syndromes 60 doxorubicin Adriamycin 60 Carvedilol 60 glycoprotein IIb IIIa inhibitors 60 follicular lymphoma FL 60 DAVANAT 60 Fulvestrant 60 Archexin 60 ergot alkaloids 60 somatostatin analogue 60 flecainide 60 known dihydropyrimidine dehydrogenase 60 Hydrochlorothiazide Tablets 60 erythematosus SLE 60 GH deficiency 60 mg kg Hematide 60 arteritis 60 dihydroergotamine DHE 60 syndrome overactive bladder 60 Arrhythmogenic 60 cystic fibrosis chronic pancreatitis 60 primary dysmenorrhea 60 iobenguane 60 lactate dehydrogenase LDH 60 IND Application 60 Inhalation Powder 60 cytogenetic abnormalities 60 docetaxel Taxotere R 60 CNS depressant 60 CIMZIA ™ 60 Cardiac Troponin 60 Hemolysis 60 Forodesine HCl 60 Itraconazole 60 cMET 60 gastrointestinal disorders ATI 60 Improves Survival 60 Chronic Myeloid Leukemia 60 irbesartan 60 Metastases 60 Recombinant Human 60 delafloxacin 60 Accelerated Partial Breast Irradiation 60 response CCyR 60 PROCTOCORT R Suppository Hydrocortisone 60 insulin glulisine 60 ACEIs 60 Renal Cell Carcinoma 60 Myelodysplastic Syndrome 60 baseline LDH 60 intact parathyroid hormone 60 thyrotoxicosis 60 Vincristine 60 squamous intraepithelial lesions 60 pan HDAC inhibitor 60 tiuxetan 60 prescribed proton pump 60 WARNINGS Myopathy Rhabdomyolysis 60 calculated creatinine clearance 60 Pegylated 60 Commonly prescribed 60 mycophenolate mofetil 60 bacterial prostatitis 60 FDA Okays 60 undergoing peritoneal dialysis 60 maximally tolerated lipid lowering 60 LV dysfunction 60 Primary endpoints 60 TM PCA3 60 Diabetic Neuropathy 60 adrenal suppression 60 SIADH 60 indinavir 60 Chronic Prostatitis 60 Omacetaxine mepesuccinate 60 Solorel TM 60 Gets FDA Clearance 60 vitreoretinal disorders 60 TNF alpha antagonist 60 pharmacodynamic parameters 60 Chemotherapy induced 60 orally administered synthetic retinoid 60 saline placebo 60 analgesic efficacy 60 thrombocytosis 60 hemostatic efficacy 60 soluble tumor necrosis 60 Pegylated Interferon 60 Luvox fluvoxamine 60 basal bolus regimen 60 relapsed refractory multiple myeloma 60 opioid tolerant 60 guanfacine extended release 60 antiretroviral naïve 60 Eraxis 60 desvenlafaxine succinate 60 cardiotoxic 60 relapsed ovarian cancer 60 Enzyme Replacement Therapy 60 hepatocellular carcinomas 60 Xelox 60 Zoraxel TM 60 standard chemotherapy regimen 60 cervical intraepithelial neoplasia 60 Bronchopulmonary Dysplasia 60 ULORIC 60 RhuDex TM 60 Advanced Melanoma 60 monoamine oxidase inhibitors 60 eosinophilic asthma 60 Tiuxetan 60 propafenone 60 patients undergoing CABG